lobbying_activities: 2677555

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2677555	e0b48d76-233c-4261-b57d-137cb9dd8e7f	Q3	JAMES EDWARDS	401027897	CONSERVATIVES FOR PROPERTY RIGHTS	2021	third_quarter	MMM	Price controls proposals regarding pharmaceuticals or other medical goods or services Interim Final Rule implementing a Most Favored Nation (MFN) Model for importing foreign price controls for certain Medicare Part B drugs (CMS-5528-IFC) H.R. 3 (Lower Drug Costs Now Act) Interim Final Rule implementing a Most Favored Nation (MFN) Model for importing foreign price controls for certain Medicare Part B drugs (CMS-5528-IFC) S.Con.Res. 14 (FY22 Budget Resolution) price control provisions to repeal noninterference clause in Medicare Parts C & D H.R. 5376 (FY 2022 Budget Reconciliation) price control provisions from H.R. 3, including repeal of noninterference clause in Medicare Parts C & D, and provisions expanding government-run health care, restrictions on private, Medicare, and Medicaid rates, coverage, and reimbursement	Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE	60000		0	0	2021-10-09T13:56:15.907000-04:00